Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma

Transarterial chemoembolization (TACE) is a widely used treatment for hepatocellular carcinoma. In order to maximize its therapeutic efficacy, doxorubicin-loaded drug-eluting beads have been developed to deliver higher doses of the chemotherapeutic agent and to prolong contact time with the tumor. T...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of hepatology Ročník 57; číslo 6; s. 1244 - 1250
Hlavní autoři:	Song, Myeong Jun, Chun, Ho Jong, Song, Do Seon, Kim, Hee Yeon, Yoo, Sun Hong, Park, Chung-Hwa, Bae, Si Hyun, Choi, Jong Young, Chang, U Im, Yang, Jin Mo, Lee, Hae Giu, Yoon, Seung Kew
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Kidlington Elsevier B.V 01.12.2012 Elsevier
Témata:	Aged Antibiotics, Antineoplastic - administration & dosage Antibiotics, Antineoplastic - adverse effects Biological and medical sciences Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - therapy Chemoembolization, Therapeutic Conventional TACE DC bead® TACE Disease Progression Doxorubicin - administration & dosage Doxorubicin - adverse effects Female Gastroenterology and Hepatology Gastroenterology. Liver. Pancreas. Abdomen Humans Liver Neoplasms - mortality Liver Neoplasms - therapy Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Middle Aged Retrospective Studies Survival Rate Time to progression Treatment response Tumors PR RECIST BCLC TACE cTACE Time to progression HCC DC bead Treatment response RFA Conventional TACE CR SD PD RCTs DEBDOX DC bead® TACE progressive disease Response Evaluation Criteria in Solid Tumors drug-eluting bead conventional TACE stable disease DC bead® loaded with doxorubicin randomized controlled studies transarterial chemoembolization partial response hepatocellular carcinoma Barcelona Clinic for Liver Cancer complete response radiofrequency ablation Antineoplastic agent Prognosis Hepatic disease Hepatocellular carcinoma Doxorubicin Isomerases Gastroenterology Evolution DNA topoisomerase (ATP-hydrolysing) Enzyme Enzyme inhibitor Instrumentation therapy Topoisomerase II inhibitor Malignant tumor Antibiotic Digestive diseases Embolization Anthracyclins Comparative study Cancer Chemoembolization
ISSN:	0168-8278, 1600-0641, 1600-0641
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!